Physician profile
Prosper Abitbol
NPI 1033108030
$7,159.75
in general payments reported to CMS, 2019-2025
37 companies · $1,264 in 2025
The $1,264 reported for 2025 was more than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,226 · 2020: $781 · 2021: $879 · 2022: $1,057 · 2023: $1,014 · 2024: $939 · 2025: $1,264.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,196 · Gift: $20.45.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,195.78 |
| Gift | $20.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,956.21 | 2019-2025 | Rinvoq, Skyrizi, Mavyret |
| Janssen Biotech, INC. | $835.95 | 2019-2025 | Tremfya, Stelara, Simponi |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $568.51 | 2019-2024 | Xifaxan, Plenvu, Trulance |
| Takeda Pharmaceuticals U.S.A., INC. | $519.44 | 2019-2024 | Entyvio |
| Pfizer INC. | $437.79 | 2020-2025 | |
| Boston Scientific Corporation | $363.75 | 2019-2025 | Axios, Wallflex Duodenal, General - Hemostasis |
| Braintree Laboratories, INC. | $250.28 | 2019-2025 | Suflave, Sutab |
| Allergan, INC. | $247.48 | 2019-2020 | |
| Janssen Scientific Affairs, LLC | $219.34 | 2022 | |
| Gilead Sciences, INC. | $178.15 | 2020-2025 | |
| Lilly USA, LLC | $174.10 | 2024-2025 | Omvoh, Mounjaro |
| Celltrion USA INC. | $150.00 | 2024 | Zymfentra |
| Merck Sharp & Dohme LLC | $129.71 | 2020-2023 | Dificid |
| Intercept Pharmaceuticals, INC. | $108.32 | 2019-2021 | |
| Madrigal Pharmaceuticals | $105.86 | 2024-2025 | Rezdiffra, Resmetirom |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $95.28 | 2021 | |
| Celgene Corporation | $94.18 | 2021-2024 | Zeposia |
| Novo Nordisk INC | $73.97 | 2023-2025 | Wegovy |
| Redhill Biopharma INC. | $71.81 | 2020-2022 | |
| Ardelyx, INC. | $71.47 | 2022-2025 | Ibsrela |
| Pentax of America, INC. | $68.85 | 2024 | Pentax Medical, C2 Cryoballoon, C2 Cryoballoon Focal Controller |
| Medtronic, INC. | $56.34 | 2025 | Endoflip |
| Qol Medical, LLC | $43.73 | 2021 | |
| Ironwood Pharmaceuticals, INC | $43.67 | 2020-2022 | |
| Ferring Pharmaceuticals INC. | $32.74 | 2021 | |
| Nestle Healthcare Nutrition INC. | $30.72 | 2020-2021 | |
| Aimmune Therapeutics, INC. | $30.05 | 2024 | |
| Erbe USA INC | $25.00 | 2024 | |
| Alnylam Pharmaceuticals INC. | $24.85 | 2022 | |
| Concordia Pharmaceuticals INC. | $24.84 | 2019 | |
| Phathom Pharmaceuticals, INC. | $23.42 | 2024 | Voquezna |
| Ipsen Biopharmaceuticals, INC | $22.58 | 2025 | Iqirvo |
| Conmed Corporation | $21.81 | 2025 | Conmed Hemostasis, Conmed Biliary, Conmed Generators |
| Genzyme Corporation | $20.96 | 2022 | |
| Organon LLC | $14.15 | 2023 | Hadlima |
| Micro-Tech Endoscopy USA, INC. | $13.12 | 2022 | |
| Cook Medical LLC | $11.32 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Prosper Abitbol listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.